Hyundai Bioscience Co (XKRX:048410) Ending Cash Position : ₩3,865 Mil (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Hyundai Bioscience Co Ending Cash Position?

Hyundai Bioscience Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩3,865 Mil.

Hyundai Bioscience Co's quarterly Ending Cash Position declined from Sep. 2023 (₩3,402 Mil) to Dec. 2023 (₩1,812 Mil) but then increased from Dec. 2023 (₩1,812 Mil) to Mar. 2024 (₩3,865 Mil).

Hyundai Bioscience Co's annual Ending Cash Position declined from Dec. 2021 (₩9,189 Mil) to Dec. 2022 (₩2,732 Mil) and declined from Dec. 2022 (₩2,732 Mil) to Dec. 2023 (₩1,812 Mil).

Hyundai Bioscience Co Ending Cash Position Historical Data

The historical data trend for Hyundai Bioscience Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Bioscience Co Ending Cash Position Chart

Hyundai Bioscience Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

5,555.13

19,215.11

9,188.84

2,732.43

1,811.88

Hyundai Bioscience Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															3,459.15	4,591.79	3,401.95	1,811.88	3,864.54

Hyundai Bioscience Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hyundai Bioscience Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2732.425	+	-920.545
	=	1,812

Hyundai Bioscience Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1811.881	+	2052.663
	=	3,865

Hyundai Bioscience Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Hyundai Bioscience Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyundai Bioscience Co (XKRX:048410) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyundai Bioscience Co Ltd (XKRX:048410) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 North-Ahyun Road, 3rd Floor Academic Cooperation Building, Ehwa Women’s University, Seodaemun-gu, Seoul, KOR

Website

http://www.hyundaibioscience.com

Hyundai Bioscience Co Ltd is a Korean biotechnology company. The company is engaged in developing and commercializing bio-fusion technology with the purpose of delivering active ingredients safely and efficiently to the body. It has developed Vitabrid CG, a biomaterial that binds vitamin C with bio-friendly mineral layers, which is a beneficial ingredient in skin brightening, anti-aging, and anti-inflammation; and Vitabrid C12, a premium skincare brand.

Hyundai Bioscience Co (XKRX:048410) Headlines

No Headlines